Literature DB >> 28973667

A novel SYN1 missense mutation in non-syndromic X-linked intellectual disability affects synaptic vesicle life cycle, clustering and mobility.

Fabrizia C Guarnieri1,2, Davide Pozzi3, Andrea Raimondi4, Riccardo Fesce5, Maria M Valente1, Vincenza S Delvecchio1, Hilde Van Esch6, Michela Matteoli3,7, Fabio Benfenati8,9, Patrizia D'Adamo1, Flavia Valtorta1,2.   

Abstract

Intellectual Disability is a common and heterogeneous disorder characterized by limitations in intellectual functioning and adaptive behaviour, whose molecular mechanisms remain largely unknown. Among the numerous genes found to be involved in the pathogenesis of intellectual disability, 10% are located on the X-chromosome. We identified a missense mutation (c.236 C > G; p.S79W) in the SYN1 gene coding for synapsin I in the MRX50 family, affected by non-syndromic X-linked intellectual disability. Synapsin I is a neuronal phosphoprotein involved in the regulation of neurotransmitter release and neuronal development. Several mutations in SYN1 have been identified in patients affected by epilepsy and/or autism. The S79W mutation segregates with the disease in the MRX50 family and all affected members display intellectual disability as sole clinical manifestation. At the protein level, the S79W Synapsin I mutation is located in the region of the B-domain involved in recognition of highly curved membranes. Expression of human S79W Synapsin I in Syn1 knockout hippocampal neurons causes aberrant accumulation of small clear vesicles in the soma, increased clustering of synaptic vesicles at presynaptic terminals and increased frequency of excitatory spontaneous release events. In addition, the presence of S79W Synapsin I strongly reduces the mobility of synaptic vesicles, with possible implications for the regulation of neurotransmitter release and synaptic plasticity. These results implicate SYN1 in the pathogenesis of non-syndromic intellectual disability, showing that alterations of synaptic vesicle trafficking are one possible cause of this disease, and suggest that distinct mutations in SYN1 may lead to distinct brain pathologies.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28973667     DOI: 10.1093/hmg/ddx352

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  18 in total

1.  Truncating biallelic variant in DNAJA1, encoding the co-chaperone Hsp40, is associated with intellectual disability and seizures.

Authors:  Saud Alsahli; Ahmed Alfares; Francisco J Guzmán-Vega; Stefan T Arold; Duaa Ba-Armah; Fuad Al Mutairi
Journal:  Neurogenetics       Date:  2019-04-10       Impact factor: 2.660

2.  Silencing of LRP1 Exacerbates Inflammatory Response Via TLR4/NF-κB/MAPKs Signaling Pathways in APP/PS1 Transgenic Mice.

Authors:  Yingying He; John Bosco Ruganzu; Quzhao Zheng; Xiangyuan Wu; Hui Jin; Xiaoqian Peng; Bo Ding; Chengheng Lin; Shengfeng Ji; Yanbing Ma; Weina Yang
Journal:  Mol Neurobiol       Date:  2020-06-22       Impact factor: 5.590

Review 3.  Reconsidering animal models used to study autism spectrum disorder: Current state and optimizing future.

Authors:  Jill L Silverman; Audrey Thurm; Sarah B Ethridge; Makayla M Soller; Stela P Petkova; Ted Abel; Melissa D Bauman; Edward S Brodkin; Hala Harony-Nicolas; Markus Wöhr; Alycia Halladay
Journal:  Genes Brain Behav       Date:  2022-03-14       Impact factor: 3.708

4.  Neuromodulator Signaling Bidirectionally Controls Vesicle Numbers in Human Synapses.

Authors:  Christopher Patzke; Marisa M Brockmann; Jinye Dai; Kathlyn J Gan; M Katharina Grauel; Pascal Fenske; Yu Liu; Claudio Acuna; Christian Rosenmund; Thomas C Südhof
Journal:  Cell       Date:  2019-10-03       Impact factor: 41.582

5.  Familial SYN1 variants related neurodevelopmental disorders in Asian pediatric patients.

Authors:  Juan Xiong; Haolin Duan; Shimeng Chen; Miriam Kessi; Fang He; Xiaolu Deng; Ciliu Zhang; Li Yang; Jing Peng; Fei Yin
Journal:  BMC Med Genomics       Date:  2021-07-09       Impact factor: 3.063

Review 6.  Postsynaptic movement disorders: clinical phenotypes, genotypes, and disease mechanisms.

Authors:  Lucia Abela; Manju A Kurian
Journal:  J Inherit Metab Dis       Date:  2018-06-13       Impact factor: 4.982

7.  Autoantibodies to synapsin I sequestrate synapsin I and alter synaptic function.

Authors:  Anna Rocchi; Silvio Sacchetti; Antonio De Fusco; Silvia Giovedi; Barbara Parisi; Fabrizia Cesca; Markus Höltje; Klemens Ruprecht; Gudrun Ahnert-Hilger; Fabio Benfenati
Journal:  Cell Death Dis       Date:  2019-11-14       Impact factor: 8.469

8.  miR‑134‑5p/Foxp2/Syn1 is involved in cognitive impairment in an early vascular dementia rat model.

Authors:  Xin Liu; Ruilin Zhang; Zimei Wu; Wenwen Si; Zhenxing Ren; Saixia Zhang; Jianhong Zhou; Dongfeng Chen
Journal:  Int J Mol Med       Date:  2019-09-05       Impact factor: 4.101

9.  Synapsins are expressed at neuronal and non-neuronal locations in Octopus vulgaris.

Authors:  Federica Maiole; Giulia Tedeschi; Simona Candiani; Luca Maragliano; Fabio Benfenati; Letizia Zullo
Journal:  Sci Rep       Date:  2019-10-28       Impact factor: 4.379

10.  Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro.

Authors:  Bo Ding; Chengheng Lin; Qian Liu; Yingying He; John Bosco Ruganzu; Hui Jin; Xiaoqian Peng; Shengfeng Ji; Yanbing Ma; Weina Yang
Journal:  J Neuroinflammation       Date:  2020-10-14       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.